The American Journal of Medicine
Volume 120, Issue 4, Supplement 1 , Pages S10-S20 , April 2007

Variability in Response to Antihypertensive Drugs

  • Barry J. Materson, MD, MBA

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Barry J. Materson, MD, MBA, Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, OPPRP (D54), PO Box 016960, Miami, Florida 33101.

References 

  1. Greenfield S, Kravitz R, Duan N, Kaplan SH. Heterogeneity of treatment effects: implications for guidelines, payment and quality assessment. Am J Med. 2007;120(suppl 4a):S3–S9
  2. Murphy WB. The Healing Heart: An Illustrated History of Cardiology. Greenwich, CT: Greenwich Press; 1998;
  3. Riva-Rocci S. Un nuovo sfigmomanometro. Gazzeta Medica di Torino. 1896;47:981–9961001–1017
  4. Riva-Rocci S. Tecnica sfigmomanometrica. Gazzeta Medica di Torino. 1897;48:161–172181–191
  5. Riva-Rocci S, Zanchetti A, Mancia G. A new sphygmomanometer: sphygmomanometric technique. J Hypertens. 1996;14:1–12
  6. Korotkov NS. Concerning the methods of blood pressure measurement (from the clinic of S. P. Fedorov). [in Russian] Proceedings of the Emperor’s Military Medical Academy of St Petersburg. 1905;11:365–367
  7. Korotkov NS. Concerning the problem of the methods of blood pressure measurement. J Hypertens. 2005;23:5
  8. Mancia G, Zanchetti A. One hundred years of auscultatory blood pressure: commemorating N (S. Korotkoff). J Hypertens. 2005;23:1–2
  9. Shlyakhto E, Conrady A. Korotkoff sounds: what do we know about its discovery?. J Hypertens. 2005;23:3–4
  10. US Department of Transportation, Federal Aviation Administration. Licenses and certificates, special issuance: hypertension [Federal Aviation Administration Web site]. Available at: http://www.faa.gov/licenses_certificates/medical_certification/specialissuance/hypertension/index.cfm. Accessed August 25, 2006.
  11. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913
  12. Kamel N, Gursoy A, Koseoglulari O, Dincer I, Gullu S. Isolated office hypertension: association with target organ damage and cardiovascular risk indices. J Natl Med Assoc. 2006;98:601–606
  13. Ayman D. The diastolic blood pressure: its variability. Arch Intern Med. 1931;48:89–97
  14. Pickering GW. In: High Blood Pressure. 2nd ed.. New York: Grune & Stratton; 1968;
  15. Modesti PA, Morabito M, Bertolozzi I, et al. Weather-related changes in 24-hour blood pressure profile: effects of age and implications for hypertension management. Hypertension. 2006;47:155–161
  16. Jones H, Atkinson G, Leary A, et al. Reactivity of ambulatory blood pressure to physical activity varies with time of day. Hypertension. 2006;47:778–784
  17. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich). 2005;7:102–109
  18. O’Brien E, Mee F, Atkins N, O’Malley K. Inaccuracy of seven popular sphygmomanometers for home measurement of blood pressure. J Hypertens. 1990;8:621–634
  19. Hamilton M, Pickering GW, Roberts JA, Sowry GS. The aetiology of essential hypertension. II (Scores for arterial blood pressures adjusted for differences in age and sex). Clin Sci (Lond). 1954;13:37–49
  20. Rose GA, Holland WW, Crowley EA. A sphygmomanometer for epidemiologists. Lancet. 1964;13:296–300
  21. Kimura A, Hashimoto J, Watabe D, et al. Patient characteristics and factors associated with inter-arm difference of blood pressure measurements in a general population in Ohasama, Japan. J Hypertens. 2004;22:2277–2283
  22. Houweling ST, Kleefstra N, Lutgers HL, et al. Pitfalls in blood pressure measurement in daily practice. Fam Pract. 2006;23:20–27
  23. Freis ED Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967;202:1028–1034
  24. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. I (Results of short-term titration with emphasis on racial differences in response). JAMA. 1982;248:1996–2003
  25. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension. Am J Cardiol. 1983;52:1230–1237
  26. Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide. Br J Clin Pharmacol. 1982;14(suppl 2):97S–101S
  27. Mokwe E, Ohmit SE, Nasser SA, et al. Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial. Hypertension. 2004;43:1202–1207
  28. Materson BJ, Reda DJ, Cushman WC, et al. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med. 1993;328:914–921
  29. Materson BJ, Reda DJ, Cushman WC Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Department of Veterans Affairs single-drug therapy of hypertension study: revised figures and new data. Am J Hypertens. 1995;8:189–192
  30. Preston RA, Materson BJ, Reda DJ, et al. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. JAMA. 1998;280:1168–1172
  31. McDowell SE, Coleman JJ, Ferner RE. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ. 2006;332:1177–1181
  32. Materson BJ, Reda D, Freis ED, Henderson WG. Cigarette smoking interferes with treatment of hypertension. Arch Intern Med. 1988;148:2116–2119
  33. Lee BL, Benowitz NL, Jacob P. Cigarette abstinence, nicotine gum, and theophylline disposition. Ann Intern Med. 1987;106:553–555
  34. Sciarrone MT, Stella P, Barlassina C, et al. ACE and α-adducin polymorphism as markers of individual response to diuretic therapy. Hypertension. 2003;41:398–403
  35. Safar ME, Benetos A. Factors influencing arterial stiffness in systolic hypertension in the elderly: role of sodium and the renin-angiotensin system. Am J Hypertens. 2003;16:249–258

PII: S0002-9343(07)00136-2

doi: 10.1016/j.amjmed.2007.02.003

The American Journal of Medicine
Volume 120, Issue 4, Supplement 1 , Pages S10-S20 , April 2007

Article Tools

* Image Usage & Resolution